Marking your calendar or using a medication app specifically designed for GLP-1 users can also help
Both companies have requested the FDA add semaglutide and tirzepatide, respectively, to its lists of drug products that present demonstrable difficulties for compounding. These DDC Lists identify substances that are considered particularly risky to compound, and drugs on these lists cannot be compounded under either 503A or 503B which could be the biggest problem for companies like Hims
These forms have never been tested in humans, and their stability, absorption, and safety are uncertain
Warning and Precautions Do NOT use Saxenda in patients with a medical history of Medullary Thyroid Carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
However, if a gland is no longer functioning due to surgical removal or advanced ovarian failure, peptides alone may not be sufficient, and direct hormone replacement may still be necessary